Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study
1School of Biotechnology, National Institute of Technology Calicut, Calicut, 673601, India.
Abstract:
Cyclophilin D (CypD) is an important regulatory protein involved in mitochondrial membrane permeability transition and cell death. Further, the mitochondrial CypD-p53 axis is an important contributor to necroptosis, a form of programmed necrosis, involved in various cardiovascular and neurological disorders. The CypD ligand, Cyclosporin A (CsA), was identified as an inhibitor of this interaction. In this study, using computational methods, we have attempted to model the CypD-p53 interaction in order to delineate their mode of binding and also to disclose the molecular mechanism, by means of which CsA interferes with this interaction. It was observed that p53 binds at the CsA-binding site of CypD. The knowledge obtained from this modelling was employed to identify novel CypD inhibitors through structure-based methods. Further, the identified compounds were tested by a similar strategy, adopted during the modelling process. This strategy could be applied to study the mechanism of protein-protein interaction (PPI) inhibition and to identify novel PPI inhibitors.
Insights
Cyclophilin D (CypD) and p53 interaction is key in programmed cell death. Computational modeling revealed Cyclosporin A (CsA) inhibits this by binding to CypD, guiding the discovery of new inhibitors.
Area of Science:
- Biochemistry and Molecular Biology
- Computational Biology
- Pharmacology
Background:
- Cyclophilin D (CypD) regulates mitochondrial permeability and cell death.
- The CypD-p53 interaction contributes to necroptosis, relevant in cardiovascular and neurological diseases.
- Cyclosporin A (CsA) is a known inhibitor of the CypD-p53 interaction.
Purpose of the Study:
- To model the CypD-p53 interaction and understand CsA's inhibitory mechanism.
- To identify novel CypD inhibitors using structure-based computational methods.
Main Methods:
- Molecular modeling of the CypD-p53 complex.
- Structure-based drug design to identify potential inhibitors.
- In silico validation of identified compounds.
Main Results:
- p53 binds to the Cyclosporin A (CsA)-binding site on Cyclophilin D (CypD).
- Computational modeling elucidated the molecular mechanism of CsA's interference.
- Novel CypD inhibitors were identified through structure-based screening.
Conclusions:
- The study provides insights into the CypD-p53 interaction and CsA inhibition.
- The developed strategy can be applied to discover inhibitors of other protein-protein interactions (PPIs).
- This approach aids in understanding and targeting PPIs involved in disease.
Related Concept Videos
Protein-protein Interfaces
Inhibition of Cdk Activity
Inhibition of CDK Activity
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Negative Regulator Molecules
Abnormal Proliferation


